glutamine and pp242

glutamine has been researched along with pp242 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ejima, Y; Gini, B; Hosoda, K; Imahori, T; Irino, Y; Kohmura, E; Kyotani, K; Masui, K; Mischel, PS; Mizowaki, T; Nagashima, H; Sasaki, R; Sasayama, T; Satoh, N; Takata, K; Tanaka, K; Yang, H	1
Chen, G; Guo, E; Guo, L; Liu, Z; Lu, H; Shan, W; Wang, C; Xia, M; Xu, Y; Zhou, B	1

Other Studies

2 other study(ies) available for glutamine and pp242

Article	Year
Compensatory glutamine metabolism promotes glioblastoma resistance to mTOR inhibitor treatment. The Journal of clinical investigation, 2015, Volume: 125, Issue:4 Topics: Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Benzophenanthridines; Brain Neoplasms; Cell Line, Tumor; Citric Acid Cycle; Drug Resistance, Neoplasm; Drug Synergism; Energy Metabolism; Gas Chromatography-Mass Spectrometry; Glioblastoma; Glutamic Acid; Glutaminase; Glutamine; Glycolysis; Humans; Indoles; Ketoglutaric Acids; Magnetic Resonance Spectroscopy; Male; Metabolome; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Targeted Therapy; Neoplasm Proteins; Protein Kinase Inhibitors; Purines; RNA, Small Interfering; Rotarod Performance Test; Signal Transduction; Temporal Lobe; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays	2015
Blockage of glutaminolysis enhances the sensitivity of ovarian cancer cells to PI3K/mTOR inhibition involvement of STAT3 signaling. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2016, Volume: 37, Issue:8 Topics: Antineoplastic Agents; Apoptosis; Benzeneacetamides; Blotting, Western; Cell Line, Tumor; Drug Resistance, Neoplasm; Female; Flow Cytometry; Gene Knockdown Techniques; Glutaminase; Glutamine; Humans; Indoles; Ovarian Neoplasms; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Purines; Real-Time Polymerase Chain Reaction; Signal Transduction; STAT3 Transcription Factor; Thiadiazoles; TOR Serine-Threonine Kinases	2016

Article

Year

Compensatory glutamine metabolism promotes glioblastoma resistance to mTOR inhibitor treatment.

The Journal of clinical investigation, 2015, Volume: 125, Issue:4

Topics: Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Benzophenanthridines; Brain Neoplasms; Cell Line, Tumor; Citric Acid Cycle; Drug Resistance, Neoplasm; Drug Synergism; Energy Metabolism; Gas Chromatography-Mass Spectrometry; Glioblastoma; Glutamic Acid; Glutaminase; Glutamine; Glycolysis; Humans; Indoles; Ketoglutaric Acids; Magnetic Resonance Spectroscopy; Male; Metabolome; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Targeted Therapy; Neoplasm Proteins; Protein Kinase Inhibitors; Purines; RNA, Small Interfering; Rotarod Performance Test; Signal Transduction; Temporal Lobe; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays

2015

Blockage of glutaminolysis enhances the sensitivity of ovarian cancer cells to PI3K/mTOR inhibition involvement of STAT3 signaling.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2016, Volume: 37, Issue:8

Topics: Antineoplastic Agents; Apoptosis; Benzeneacetamides; Blotting, Western; Cell Line, Tumor; Drug Resistance, Neoplasm; Female; Flow Cytometry; Gene Knockdown Techniques; Glutaminase; Glutamine; Humans; Indoles; Ovarian Neoplasms; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Purines; Real-Time Polymerase Chain Reaction; Signal Transduction; STAT3 Transcription Factor; Thiadiazoles; TOR Serine-Threonine Kinases

2016